Your Cart ( 1 Item )

• A Phase 2, Open-Label, Investigator-Initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects With Recalcitrant Allergic Contact or Atopic Dermatitis
  March 2012 | Volume 11 | Issue 3 | Original Article | 341 | Copyright © March 2012
  

  Eva M. Volf MD,^a Shiu-Chung Au MD,^b Nicole Dumont,^b Pamela Scheinman MD,^b Alice B. Gottlieb MD PhD^a,b

  ^aTufts University School of Medicine, Boston, MA ^bTufts Medical Center, Boston, MA

  
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs